News | Clinical Decision Support | April 29, 2015

Gregg W. Stone Appointed to COR Medical Technologies' Senior Editorial Board

Columbia University Medical center physician, professor brings cardiovascular expertise to review of current medical research, conditions and treatments

April 29, 2015 — COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior Editorial Board. 

Stone is a professor of medicine at Columbia University and the director of cardiovascular research and education for the Center for Interventional Vascular Therapy at the Columbia University Medical Center and New York Presbyterian Hospital in New York City. Stone also serves as the co-director of medical research and education at the Cardiovascular Research Foundation in New York. 

COR’s Senior Editorial Board provides input on current medical research, conditions and treatments. The board reviews conditions and best practice treatments in order to provide instant decision support from the most current, vetted information available to treat cardiovascular conditions.

“We are pleased to have Dr. Stone join the COR Senior Editorial Board,” said Vince Friedewald, M.D., COR founder and CEO.  “His cardiovascular and interventional vascular therapy experience adds great value to our team.”

Stone received his medical degree from the John Hopkins School of Medicine in Baltimore and completed his residency in internal medicine at the New York Hospital – Cornell Medical Center in New York City.  He trained in cardiology at Cedars-Sinai Medical Center in Los Angeles, and in advanced angioplasty at the Mid-America Heart Institute in Kansas City, Missouri. He is board certified by the American Board of Interventional Cardiology, American Board of Cardiovascular Diseases and American Board of Internal Medicine.

“I am honored to join the distinguished group of medical experts who sit on the COR Medical Technologies Senior Editorial Board,” said Stone. “I am excited to share my experience in cardiovascular medicine with the other members.”

COR Medical Technologies offers CORcare, a comprehensive instant decision support system for rapid and accurate diagnosis, treatment and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system.

For more information: www.cormedtec.com

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init